The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Mixed Despite Positive Vaccine News

Wed, 30th Dec 2020 11:57

(Alliance News) - Stocks in London were lacking direction on Wednesday midday, amid growing Covid-19 case numbers, and despite Oxford/AstraZeneca vaccine rollout optimism.

The FTSE 100 index was up 4.87 points, or 0.1%, at 6,607.52 on Wednesday. The FTSE 250 index was down 37.98 points, or 0.2%, at 20,859.61 and the AIM All-Share index was up 0.2% at 1,151.80.

The Cboe UK 100 index was up 0.1% at 658.51. The Cboe 250 was down 0.2% at 18,258.70, and the Cboe Small Companies flat at 11,753.33.

In mainland Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were both flat in the afternoon.

Sterling was quoted at USD1.3600 on Wednesday, jumping from USD1.3509 at the London equities close on Tuesday and reflecting post-Brexit trade deal optimism.

The EU signed the post-Brexit deal on Wednesday, setting it on path to be provisionally implemented after UK Prime Minister Boris Johnson is scheduled to sign it for London in the afternoon.

European Commission President Ursula von der Leyen and European Council chief Charles Michel put their ink on the agreement on Wednesday morning - just a week after the deal had been struck.

The 27 EU ambassadors gave their go-ahead for the provisional application on Tuesday afternoon.

The deal - which provides for zero tariffs and zero quotas between the trading partners - still needs to be ratified by the European Parliament.

The European Commission proposed a period of provisional application until February 28, but this might be extended if the lawmakers are scheduled to give their approval in March.

Also on Wednesday, UK parliament will vote on whether to accept the deal.

The euro traded at USD1.2270, firming from USD1.2246 late Tuesday.

On the LSE, AstraZeneca said its Covid-19 vaccine has been approved for emergency supply in the UK, with the first doses being released on Wednesday so that vaccinations may begin early in the New Year.

FTSE 100-listed Astra shares were up 0.4% on Wednesday midday.

The pharmaceutical firm said it aims to supply millions of doses in the first quarter as part of an agreement with the UK government to supply up to 100 million doses in total.

The vaccine was authorised by the UK Medicines & Healthcare Products Regulatory Agency, recommending two doses administered with an interval of between four and 12 weeks. Clinical trials showed the vaccine to be safe and effective at preventing symptomatic Covid-19, with no severe cases and no hospitalisations more than 14 days after the second dose.

The first doses will be released Wednesday in order for vaccinations to start early in the new year, Astra said.

The vaccine has been approved for the immunization of people aged 18 and over, with the authorisation recommending two doses administered with an interval of four to 12 weeks.

"Key news in the UK is the Oxford/AstraZeneca vaccine authorisation, which brings forward a potential end to further restrictions given the easier logistical and storage requirements. That said, Health Secretary Matt Hancock is expected to announce additional mobility rules within the coming days as cases continue to rise," said Axi analyst Stephen Innes.

More areas in England will be placed under the country's toughest coronavirus restrictions, Health Secretary Matt Hancock is expected to tell the Commons on Wednesday.

Pressure mounted on the government to act as hospitals across England warned of increasing strains on services due to Covid-19 patient numbers, which have reached their highest levels during the pandemic, while 51,135 further cases and 414 deaths were reported on Tuesday.

Johnson chaired a meeting of the government's Covid-19 Operations committee on Tuesday evening, when changes to the tier system were discussed.

With case rates rising in all regions of England, as well as the number of Covid-19 patients in hospitals, any review is likely to involve areas moving up a tier rather than down.

Areas that may be moved from Tier 3 to Tier 4 due to increasing case rates include parts of the East Midlands, such as Northamptonshire and Leicestershire, as well as all areas of the West Midlands metropolitan county.

Hartlepool in north-east England, along with a handful of areas in Lancashire – Blackburn with Darwen, Burnley, Pendle and Ribble Valley – could also be upgraded from Tier 3 to 4.

Back on the LSE, Flutter Entertainment was up 1.2% after saying that completion of the 37% of the issued and outstanding units of FanDuel Group has occurred.

At the end of November, Flutter had entered an agreement with Fastball Holdings to acquire the latter's stake in FanDuel for USD4.18 billion, which will raise Flutter's stake in the fantasy sports, casino and horse racing business to 95% from 59%.

The buy "materially increases exposure to US market", Flutter said at the time, "the most attractive sector opportunity today".

Among the mid-caps, Energean was up 2.1% after reaching an agreement with Kerogen Investments, an affiliate of Kerogen Capital, for the acquisition of Kerogen's 30% shareholding in Energean Israel. This will result in Energean owning 100% of the Israeli business.

A total consideration of between USD380 million and USD405 million, the Mediterranean-focused gas exploration and production company said.

Energean said the acquisition adds 2P reserves of 29.5 billion cubic metres of gas and 30 million barrels of liquids, representing 219 million barrels of oil equivalent in total, to the company.

Taking a 100% interest in Energean Israel will enable Energean to fully control its capital structure, it said, enhancing its ability to maximise total shareholder returns.

Elsewhere, iEnergizer jumped 14% after entering into a credit agreement for a new five-year senior secured term loan facility for USD165 million.

The IT service management company said it intends to utilise the additional financing now available to return cash to shareholders.

Gold was quoted at USD1,880.00 an ounce on Wednesday, slightly lower than USD1,882.29 on Tuesday. Brent oil was trading at USD51.62 a barrel, up on USD51.16 late Tuesday.

The US is called for a higher start, with the Dow Jones and S&P 500 both pointed up 0.4% and the Nasdaq Composite up 0.3%.

Against the yen, the dollar was quoted at JPY103.14, down from JPY103.51.

A quiet economic calendar on Wednesday has the US goods trade balance numbers at 1330 GMT.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.